Missouri Code of State Regulations › Title 20 - DEPARTMENT OF COMMERCE AND INSURANCE › Division 2150 - State Board of Registration for the Healing Arts › Chapter 2 - Licensing of Physicians and Surgeons › Section 20 CSR 2150-2.170 - Human Chorionic Gonadotropin (HCG) of No Medical or Osteopathic Value in the Treatment of Obesity or Weight Loss

Current through Register Vol. 49, No. 14, July 15, 2024
PURPOSE: This rule provides clarification of the
				  approved use of Human Chorionic Gonadotropin (HCG).
(1) Pursuant to authority granted to the
				board by section 334.100.2(4)(f), RSMo, the board declares the use of Human
				Chorionic Gonadotropin (HCG) on a patient is of no medical or osteopathic value
				in weight loss or the treatment of obesity.
(2) The board shall not seek disciplinary
				action against a licensee based solely on the use of HCG for weight loss and
				obesity treatment if the licensee has the patient sign the Informed Consent for
				HCG form, included herein
,
before beginning the non-approved
				use of HCG on a patient.
Informed Consent for Human Chorionic
				  Gonadotropin (HCG)
Patient's Name:
				  _______________________________________
Address: _______________________________________
_______________________________________
Age: _______ Sex: ___Male ____Female
Name and Address of Treating Physician:
Malignancy, disease, illness or physical condition diagnosed
				  for medical treatment with HCG:
My physician has explained to me and I fully
				  understand:
(a) that the FDA package
				insert for HCG states, "HCG has not been demonstrated to be effective
				adjunctive therapy in the treatment of obesity. There is no substantial
				evidence that it increases weight loss beyond that resulting from caloric
				restriction, that it causes a more attractive or 'normal' distribution of fat,
				or that it decreases the hunger and discomfort associated with
				calorie-restricted diets";
(b)
				because of the potential for side effects, the FDA package insert suggests that
				HCG should be used with caution in patients with certain conditions, including
				cardiac diseases, renal disease, epilepsy, migraine and asthma;
(c) that the American Society of Bariatric
				Physicians has issued a position statement that the use of HCG for weight loss
				is not recommended. Bariatric medicine is the field of medicine which
				specializes in the evaluation and treatment of overweight people through
				medical management;
(d) prior to
				prescribing medication for weight loss a physician should obtain a complete
				medical history, perform a comprehensive physical examination of the patient
				and order appropriate tests to include, but not limited to, an EKG and tests of
				thyroid function, liver function, and kidney function to confirm that there are
				no medical conditions which are a contraindication to the use of HCG;
(e) that there are no peer-reviewed studies
				supporting the use of HCG in weight loss;
(f) that the federal government and most
				insurance companies do not pay for or reimburse for treatment with
				HCG;
(g) that the Missouri State
				Board of Registration for the Healing Arts has monitored the development of the
				scientific literature on HCG and has concluded that HCG has been
				authoritatively demonstrated to be
ineffective
in the
				treatment of obesity and weight loss;
(h) that the Missouri State Board of Registration for
				the Healing Arts has determined that the use of HCG for obesity or weight loss
				by Missouri citizens may be harmful to their health;
(i) as of December 6, 2011, the FDA has
				prohibited the sale of "homeopathic" and over the counter HCG diet products and
				declared them fraudulent and illegal;
(j) that neither the American Medical
				Association, the American Osteopathic Association, nor any other recognized
				independent medical association recommend the use of HCG for the treatment of
				obesity or weight loss;
(k) that
				the Missouri State Board of Registration for the Healing Arts strongly
				recommends that Missouri citizens not undergo HCG treatment for obesity or
				weight loss; and
(l) that treatment
				with HCG may not begin until three business days have expired after the date of
				my execution of this informed consent.
__________________________________
				  ______________________
Physician's Signature Date
I have read and understand the above. Notwithstanding having
				  read and understood the above, I hereby elect to undergo treatment with
				  HCG.
__________________________________
				  ________________________
Patient's Signature Date